Clinical Trial Update: Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for AJU-A51 in type 2 diabetes reports efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AJU-A51

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Type2 Diabetes | Phase 3 | Status: COMPLETED